Pediatric high-grade glioma (HGG) and pilocytic-astrocyoma/optic-pathway gliomas (PA+OPG) are each very vascular tumors but vary substantially in their treatment, clinical course and long term prognosis. In this study we demonstrate that measurements that work in adults to distinguish tumor grades (eg RCBV) cannot distinguish between pediatric HGG and PA+OPG, but a new MRI biomarker, the ratio of standardized RCBV (sRCBV) to mean diffusivity (MD) can cleanly making this distinction. This finding has significant implications for treatment management in the pediatric brain tumor population.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords